Trial site
Changzhou No.2 People's Hospital
- 9running trials
- 12closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease3 trials
- Colorectal cancer2 trials
- Heart failure2 trials
- Lung cancer2 trials
- Obesity2 trials
- Type 2 diabetes2 trials
- Ulcerative colitis2 trials
- ANCA-associated vasculitis1 trial
- Atrial fibrillation1 trial
- Crohn's disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Gastric and oesophageal cancer1 trial
- and 7 more
- Phase
- Phase 314 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Completed12 trials
- Active, not recruiting5 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company6 trials
- Novo Nordisk A/S5 trials
- Changzhou No.2 People's Hospital2 trials
- Alebund Pharmaceuticals1 trial
- Daiichi Sankyo1 trial
- and 6 more
Running trials
Not yet recruiting
UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases
Recruiting
FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer
Active, not recruiting
Recruiting
FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension
Active, not recruiting
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- ANCA-associated vasculitis1 recruiting
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- High blood pressure1 recruiting
- Lupus (SLE)1 recruiting
- Myasthenia gravis1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Completed
Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
Completed
A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight
Completed
AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
Completed
Completed
Completed
Completed
Completed
Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026